Analytical Data
-
基因名
RT0041
- Application
-
别名
/
-
种属
Rickettsia typhi
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q68XW4
-
表达区间
70-147aa
-
分子量
15.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RT0041 is a recombinant protein that has garnered attention in the field of biomedical research due to its potential applications in therapeutic development and disease modeling. The background of the study on RT0041 stems from the increasing interest in protein-based therapies, particularly in tackling complex diseases such as cancer and autoimmune disorders. This protein is derived from a specific gene that encodes for a protein involved in critical biological processes, including cell signaling and immune response modulation. As researchers seek to understand the underlying mechanisms of various diseases, the study of RT0041 provides insight into its structural and functional characteristics. Investigations have shown that RT0041 may play a role in enhancing cellular responses, making it a candidate for targeted therapies. Furthermore, the recombinant production of RT0041 allows for large-scale availability and standardized quality, which is crucial for preclinical and clinical applications. By elucidating the properties and mechanisms of action of RT0041, researchers aim to explore its potential as a therapeutic agent and its implications in advancing personalized medicine. Overall, the study of RT0041 not only contributes to our understanding of protein functionality but also opens avenues for innovative treatment strategies in various diseases.
